As per this study, the Global Osteoarthritis Drug Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.
Osteoarthritis is the type of arthritis; characterized by joint inflammation, joint pain, swelling and stiffness. It is the medical condition, which results from break down of joint cartilage. The osteoarthritis can be treated by life style changes, physical measures, medications, therapies, surgeries or joint replacement.
The market is gaining high demand on the account of the rapid increase in the count of the patients suffering from osteoarthritis. The increasing aged population and increase in prevalence of bone diseases and obesity is driving the market growth. The rise in R&D activities, availability of innovative & advanced treatments is further contributing the market growth. On the flip side, the high cost of treatment is likely to hinder the growth of this market.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of osteoarthritis drug.
The broad osteoarthritis drug market has been sub-grouped into drug class, route of administration and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Drug Class
By Route Of Administration
By Distribution Channel
- Viscosupplementation Agents
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for osteoarthritis drug in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Osteoarthritis Drug Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the osteoarthritis drug market include Alkem Laboratories, Anika Therapeutics, Inc., Bioventus, Inc., Chugai Pharmaceutical Co., Limited, Ferring B.V., Horizon Pharma plc, Pfizer Inc., Sanofi, Flexion Therapeutics, Inc. and Zimmer Biomet Holdings, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
2. EXECUTIVE SUMMARY
- Introduction To Osteoarthritis Drug
- Report Description
- Objectives Of The Study
- Research Scope
- Research Methodology
3. MARKET ANALYSIS
- Market Highlight
- Global Osteoarthritis Drug Market: Snapshot
4. OSTEOARTHRITIS DRUG MARKET ANALYSIS BY DRUG CLASS
- Porter’s Five Forces Analysis
- Value Chain Analysis
5. OSTEOARTHRITIS DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- Market In Corticosteroids
- Market In NSAIDS
- Market In Viscosupplementation Agents
- Market In Others
6. OSTEOARTHRITIS DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- Market In Oral
- Market In Parenteral
- Market In Topical
7. OSTEOARTHRITIS DRUG MARKET ANALYSIS BY GEOGRAPHY
- Market In Hospital Pharmacies
- Market In Retail Pharmacies
- Market In Online Pharmacies
8. COMPETITIVE LANDSCAPE OF THE OSTEOARTHRITIS DRUG COMPANIES
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
9. COMPANY PROFILES OF THE OSTEOARTHRITIS DRUG INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- Market Competition
- Mergers And Acquisitions
- New Product Launches
- Other Developments
* Tentative TOC
LIST OF TABLES
- Alkem Laboratories
- Anika Therapeutics, Inc.
- Bioventus, Inc.
- Chugai Pharmaceutical Co., Limited
- Ferring B.V.
- Horizon Pharma plc.
- Pfizer Inc.
- Sanofi, Flexion Therapeutics, Inc.
- Zimmer Biomet Holdings, Inc.
Table 1. Market Highlights Of Osteoarthritis Drug
Table 2. Global Osteoarthritis Drug Market By Drug Class
Table 3. Global Osteoarthritis Drug Market By Route Of Administration
Table 4. Global Osteoarthritis Drug Market By Distribution Channel
Table 5. Global Osteoarthritis Drug Market By Geography
Table 6. North America Osteoarthritis Drug Market
Table 7. Europe Osteoarthritis Drug Market
Table 8. Asia Pacific Osteoarthritis Drug Market
Table 9. Latin America Osteoarthritis Drug Market
Table 10. Middle East And Africa Osteoarthritis Drug Market
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Osteoarthritis Drug Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Osteoarthritis Drug
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Osteoarthritis Drug Market By Drug Class
Fig. 8. Global Osteoarthritis Drug Market By Route Of Administration
Fig. 9. Global Osteoarthritis Drug Market By Distribution Channel
Fig. 10. Global Osteoarthritis Drug Market By Geography
Fig. 11. North America Osteoarthritis Drug Market
Fig. 12. Europe Osteoarthritis Drug Market
Fig. 13. Asia Pacific Osteoarthritis Drug Market
Fig. 14. Latin America Osteoarthritis Drug Market
Fig. 15. Middle East And Africa Osteoarthritis Drug Market
Fig. 16. Market Share Of Osteoarthritis Drug Companies
Fig. 17. Recent Developments In Osteoarthritis Drug Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.